DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 77.28.
Share Price | ₹4,025.4 | Apr 26,2024 |
Market Cap | ₹106,873.0 Cr | |
Earnings-TTM | ₹1,383.0 Cr | TTM-Consolidated Results |
Price/Earnings | 77.28x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹106,873.0 Cr] as on Apr 26,2024
(/) Earnings [ ₹1,383.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 77.28x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 77.28 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 40.19x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 39.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2021 at 48.56x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2019 of 33.42x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
DIVIS LABORATORIES | 1,382.97 | 77.28 | 106,873.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.11 | 360,920.0 |
CIPLA LTD | 3,744.03 | 30.39 | 113,794.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 20.02 | 104,316.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 32.29 | 95,380.9 |
MANKIND PHARMA LTD | 1,743.30 | 54.42 | 94,869.4 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 60.95 | 91,057.0 |
LUPIN LTD | 1,809.74 | 40.69 | 73,642.4 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.86 | 66,278.5 |
ABBOTT INDIA LTD | 1,145.58 | 47.98 | 54,961.0 |
ALKEM LABORATORIES LTD | 1,574.66 | 37.22 | 58,604.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.02x |
Max industry PE | 77.28x |
Median industry PE | 40.11x |
Average industry PE | 42.29x |
You may also like the below Video Courses